Search

everythinglearnresearchcommunity

for

Search:↓

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Adult tissue stem cells can adapt and switch roles to help repair and maintain the body.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.

Peptide hydrogels are promising for drug delivery and tissue repair in medicine.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Targeting endolysosomes may help treat COVID-19.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Advances in mechanobiology and immunology could lead to scarless wound healing.

Vitamin A affects hair loss and immune response in alopecia areata.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

Thrombospondin-1 is crucial for hair follicle regression and reduced blood vessel growth during the catagen phase.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

Improving topical drug delivery involves overcoming skin barriers and using personalized dosing to enhance effectiveness.

Curcumin shows promise in reducing pain and inflammation, but more research is needed.

Entospletinib effectively prevents eye and skin GVHD in mice.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Blocking the Wnt/β‐catenin pathway can speed up wound healing, reduce scarring, and improve cartilage repair.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.

Keratins 6, 16, and 17 increase in damaged or diseased skin and may help diagnose skin issues.

Smart delivery methods for CRISPR gene editing are crucial for clinical success.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.